[Form 4] INTERPARFUMS INC Insider Trading Activity

Rhea-AI Filing Summary

Interparfums Inc. director and Global Chief Commercial Officer Herve Bouillonnec reported exercising stock options and acquiring common shares. On 12/15/2025, he exercised options and acquired 1,500 shares of Interparfums common stock at $73.09 per share, leaving him with 1,500 shares beneficially owned directly after the transaction. The filing shows the corresponding option awards for 300-share tranches at a $73.09 exercise price being fully exercised and reduced to zero.

He continues to hold multiple remaining option awards to buy Interparfums common stock, including grants with exercise prices of $97.84, $147.71, and $130.6, with expiration dates ranging from late 2028 to late 2030, each covering between 800 and 1,000 underlying shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bouillonnec Herve

(Last) (First) (Middle)

551 5TH AVENUE

(Street)

NEW YORK NY 10176

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTERPARFUMS INC [ IPAR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Chief Commercial Office

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								0	D
Common Stock	12/15/2025		M		1,500	A	$73.09	1,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option-right to buy	$73.09	12/15/2025		M			300	12/31/2020	12/30/2025	Common Stock	300	$0	0	D
Option-right to buy	$73.09	12/15/2025		M			300	12/31/2021	12/30/2025	Common Stock	300	$0	0	D
Option-right to buy	$73.09	12/15/2025		M			300	12/31/2022	12/30/2025	Common Stock	300	$0	0	D
Option-right to buy	$73.09	12/15/2025		M			300	12/31/2023	12/30/2025	Common Stock	300	$0	0	D
Option-right to buy	$73.09	12/15/2025		M			300	12/31/2024	12/30/2025	Common Stock	300	$0	0	D
Option-right to buy	$97.84							12/31/2023	12/30/2028	Common Stock	1,000		1,000	D
Option-right to buy	$97.84							12/31/2024	12/30/2028	Common Stock	1,000		1,000	D
Option-right to buy	$97.84							12/31/2025	12/30/2028	Common Stock	1,000		1,000	D
Option-right to buy	$97.84							12/31/2026	12/30/2028	Common Stock	1,000		1,000	D
Option-right to buy	$97.84							12/31/2027	12/30/2028	Common Stock	1,000		1,000	D
Option-right to buy	$147.71							12/29/2024	12/28/2029	Common Stock	800		800	D
Option-right to buy	$147.71							12/29/2025	12/28/2029	Common Stock	800		800	D
Option-right to buy	$147.71							12/29/2026	12/28/2029	Common Stock	800		800	D
Option-right to buy	$147.71							12/29/2027	12/28/2029	Common Stock	800		800	D
Option-right to buy	$147.71							12/29/2028	12/28/2029	Common Stock	800		800	D
Option-right to buy	$130.6							12/31/2025	12/30/2030	Common Stock	800		800	D
Option-right to buy	$130.6							12/31/2026	12/30/2030	Common Stock	800		800	D
Option-right to buy	$130.6							12/31/2027	12/30/2030	Common Stock	800		800	D
Option-right to buy	$130.6							12/31/2028	12/30/2030	Common Stock	800		800	D
Option-right to buy	$130.6							12/31/2029	12/30/2030	Common Stock	800		800	D

Explanation of Responses:

	/s/ Herve Bouillonnec by Joseph A. Caccamo as attorney-in-fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.